Human cathelicidin peptide LL-37 modulates the effects of IFN-γ on APCs

Journal of Immunology

Volumn 183, Issue 9, 2009, Pages 5788-5798

  Nijnik, Anastasia ^a   Pistolic, Jelena ^a   Wyatt, Aaron ^a   Tam, Sheena ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GAMMA INTERFERON; STAT1 PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIMICROBIAL CATIONIC PEPTIDES; CATHELICIDINS; CELL LINE; CELLS, CULTURED; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; MICE; MOLECULAR SEQUENCE DATA; MONOCYTES; RECOMBINANT PROTEINS; STAT1 TRANSCRIPTION FACTOR; TH1 CELLS;

EID: 77954143033     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901491     Document Type: Article

References (62)

1. Zanetti, M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukocyte Biol. 75: 39-48.
2. Durr, U. H., U. S. Sudheendra, and A. Ramamoorthy. 2006. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 1758: 1408-1425.
3. Nijnik, A., and R. E. W. Hancock. 2009. The roles of cathelicidin LL-37 in immune defenses and novel clinical applications. Curr. Opin. Hematol. 16: 41-47.
4. De, Y., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192: 1069-1074.
5. Niyonsaba, F., K. Iwabuchi, A. Someya, M. Hirata, H. Matsuda, H. Ogawa, and I. Nagaoka. 2002. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106: 20-26. (Pubitemid 34437873)
6. Mookherjee, N., K. L. Brown, D. M. Bowdish, S. Doria, R. Falsafi, K. Hokamp, F. M. Roche, R. Mu, G. H. Doho, J. Pistolic, et al. 2006. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176: 2455-2464.
7. 2 production from mast cells. Eur. J. Immunol. 31: 1066-1075.
8. Zheng, Y., F. Niyonsaba, H. Ushio, I. Nagaoka, S. Ikeda, K. Okumura, and H. Ogawa. 2007. Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human α-defensins from neutrophils. Br. J. Dermatol. 157: 1124-1131.
9. Barlow, P. G., Y. Li, T. S. Wilkinson, D. M. Bowdish, Y. E. Lau, C. Cosseau, C. Haslett, A. J. Simpson, R. E. W. Hancock, and D. J. Davidson. 2006. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J. Leukocyte Biol. 80: 509-520.
10. Nagaoka, I., H. Tamura, and M. Hirata. 2006. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J. Immunol. 176: 3044-3052. (Pubitemid 43306966)
11. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
12. Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. W. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169: 3883-3891.
13. Di Nardo, A., M. H. Braff, K. R. Taylor, C. Na, R. D. Granstein, J. E. McInturff, S. Krutzik, R. L. Modlin, and R. L. Gallo. 2007. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J. Immunol. 178: 1829-1834.
14. Kandler, K., R. Shaykhiev, P. Kleemann, F. Klescz, M. Lohoff, C. Vogelmeier, and R. Bals. 2006. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int. Immunol. 18: 1729-1736.
15. Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y. H. Wang, B. Homey, W. Cao, Y. H. Wang, B. Su, F. O. Nestle, et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569.
16. Davidson, D. J., A. J. Currie, G. S. Reid, D. M. Bowdish, K. L. MacDonald, R. C. Ma, R. E. W. Hancock, and D. P. Speert. 2004. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172: 1146-1156.
17. Pulendran, B., K. Palucka, and J. Banchereau. 2001. Sensing pathogens and tuning immune responses. Science 293: 253-256.
18. Yu, J., N. Mookherjee, K. Wee, D. M. Bowdish, J. Pistolic, Y. Li, L. Rehaume, and R. E. W. Hancock. 2007. Host defense peptide LL-37, in synergy with in- flammatory mediator IL-1β, augments immune responses by multiple pathways. J. Immunol. 179: 7684-7691.
19. Bowdish, D. M., D. J. Davidson, D. P. Speert, and R. E. W. Hancock. 2004. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 172: 3758-3765. (Pubitemid 38337960)
20. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-γ: an overview of signals, mechanisms and functions. J. Leukocyte Biol. 75: 163-189.
21. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15: 749-795.
22. Leon, M. L., and S. H. Zuckerman. 2005. γ Interferon: a central mediator in atherosclerosis. Inflamm. Res. 54: 395-411.
23. Grau, G. E., H. Heremans, P. F. Piguet, P. Pointaire, P. H. Lambert, A. Billiau, and P. Vassalli. 1989. Monoclonal antibody against interferon γ can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 86: 5572-5574.
24. Miu, J., N. H. Hunt, and H. J. Ball. 2008. Predominance of interferon-related responses in the brain during murine malaria, as identified by microarray analysis. Infect. Immun. 76: 1812-1824.
25. Yin, K., E. Gribbin, and H. Wang. 2005. Interferon-γ inhibition attenuates lethality after cecal ligation and puncture in rats: implication of high mobility group box-1. Shock 24: 396-401.
26. Spiller, S., G. Elson, R. Ferstl, S. Dreher, T. Mueller, M. Freudenberg, B. Daubeuf, H. Wagner, and C. J. Kirschning. 2008. TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice. J. Exp. Med. 205: 1747-1754.
27. Doherty, G. M., J. R. Lange, H. N. Langstein, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1992. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J. Immunol. 149: 1666-1670.
28. Heremans, H., J. Van Damme, C. Dillen, R. Dijkmans, and A. Billiau. 1990. Interferon γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171: 1853-1869.
29. Shuai, K., and B. Liu. 2003. Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 3: 900-911.
30. Ramana, C. V., M. P. Gil, R. D. Schreiber, and G. R. Stark. 2002. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23: 96-101.
31. Ramana, C. V., M. P. Gil, Y. Han, R. M. Ransohoff, R. D. Schreiber, and G. R. Stark. 2001. Stat1-independent regulation of gene expression in response to IFN-γ. Proc. Natl. Acad. Sci. USA 98: 6674-6679.
32. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
33. Szabo, S. J., B. M. Sullivan, S. L. Peng, and L. H. Glimcher. 2003. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21: 713-758.
34. Sidman, C. L., J. D. Marshall, L. D. Shultz, P. W. Gray, and H. M. Johnson. 1984. γ-Interferon is one of several direct B cell-maturing lymphokines. Nature 309: 801-804.
35. Snapper, C. M., C. Peschel, and W. E. Paul. 1988. IFN-γ stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140: 2121-2127.
36. Schroder, K., M. J. Sweet, and D. A. Hume. 2006. Signal integration between IFNγ and TLR signalling pathways in macrophages. Immunobiology 211: 511-524.
37. Held, T. K., X. Weihua, L. Yuan, D. V. Kalvakolanu, and A. S. Cross. 1999. γ Interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor α and interleukin-1. Infect. Immun. 67: 206-212.
38. Kovarik, P., D. Stoiber, M. Novy, and T. Decker. 1998. Stat1 combines signals derived from IFN-γ and LPS receptors during macrophage activation. EMBO J. 17: 3660-3668.
39. Dao, D. N., L. Kremer, Y. Guerardel, A. Molano, W. R. Jacobs, Jr., S. A. Porcelli, and V. Briken. 2004. Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect. Immun. 72: 2067-2074.
40. Darveau, R. P., and R. E. W. Hancock. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155: 831-838.
41. Della Bella, S., S. Giannelli, A. Taddeo, P. Presicce, and M. L. Villa. 2008. Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays. J. Immunol. Methods 339: 153-164.
42. Sansom, D. M., C. N. Manzotti, and Y. Zheng. 2003. What's the difference between CD80 and CD86? Trends Immunol. 24: 314-319.
43. Bhatia, S., M. Edidin, S. C. Almo, and S. G. Nathenson. 2006. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol. Lett. 104: 70-75.
44. Kagan, J. C., T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon- β. Nat. Immunol. 9: 361-368.
45. Stavnezer, J., J. E. Guikema, and C. E. Schrader. 2008. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26: 261-292.
46. Goh, K. C., S. J. Haque, and B. R. Williams. 1999. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 18: 5601-5608.
47. Varinou, L., K. Ramsauer, M. Karaghiosoff, T. Kolbe, K. Pfeffer, M. Muller, and T. Decker. 2003. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-γ-dependent innate immunity. Immunity 19: 793-802.
48. Gough, D. J., D. E. Levy, R. W. Johnstone, and C. J. Clarke. 2008. IFNγ signaling: does it mean JAK-STAT? Cytokine Growth Factor Rev. 19: 383-394.
49. An, L. L., Y. H. Yang, X. T. Ma, Y. M. Lin, G. Li, Y. H. Song, and K. F. Wu. 2005. LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR (J6-1) DNA vaccine. Leuk. Res. 29: 535-543.
50. Kurosaka, K., Q. Chen, F. Yarovinsky, J. J. Oppenheim, and D. Yang. 2005. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174: 6257-6265.
51. Chuang, C. M., A. Monie, A. Wu, C. P. Mao, and C. F. Hung. 2009. Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer. Hum. Gene Ther. 20: 303-313.
52. Cerutti, A. 2008. Location, location, location: B-cell differentiation in the gut lamina propria. Mucosal Immunol. 1: 8-10.
53. Fagarasan, S., K. Kinoshita, M. Muramatsu, K. Ikuta, and T. Honjo. 2001. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413: 639-643.
54. Fiset, P. O., L. Cameron, and Q. Hamid. 2005. Local isotype switching to IgE in airway mucosa. J. Allergy Clin. Immunol. 116: 233-236.
55. Hunt, N. H., and G. E. Grau. 2003. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24: 491-499.
56. Moreno, S. E., J. C. Alves-Filho, T. M. Alfaya, J. S. da Silva, S. H. Ferreira, and F. Y. Liew. 2006. IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J. Immunol. 177: 3218-3224.
57. Randow, F., W. D. Docke, D. S. Bundschuh, T. Hartung, A. Wendel, and H. D. Volk. 1997. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-γ, IL-12, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 158: 2911-2918.
58. Silverberg, M. S., J. H. Cho, J. D. Rioux, D. P. McGovern, J. Wu, V. Annese, J. P. Achkar, P. Goyette, R. Scott, W. Xu, et al. 2009. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat. Genet. 41: 216-220.
59. Yamasaki, K., A. Di Nardo, A. Bardan, M. Murakami, T. Ohtake, A. Coda, R. A. Dorschner, C. Bonnart, P. Descargues, A. Hovnanian, et al. 2007. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13: 975-980.
60. Murakami, M., B. Lopez-Garcia, M. Braff, R. A. Dorschner, and R. L. Gallo. 2004. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172: 3070-3077. (Pubitemid 38263696)
61. Hancock, R. E. W., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24: 1551-1557.
62. Mookherjee, N., L. M. Rehaume, and R. E. W. Hancock. 2007. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 11: 993-1004.